Toronto Dominion Bank’s Gilead Sciences GILD Stock Holding History

Toronto Dominion Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.36M	Buy	+60,000	New	+$8.4M	0.01%	686
2019 Q3	–	Sell	-41,600	Closed	-$1.41M	–	1539
2019 Q2	$1.41M	Sell	41,600 -237,800	-85%	-$15.6M	﹤0.01%	897
2019 Q1	$18.2M	Buy	279,400 +174,800	+167%	+$11.6M	0.03%	323
2018 Q4	$6.54M	Sell	104,600 -10,400	-9%	-$727K	0.01%	562
2018 Q3	$8.88M	Sell	115,000 -59,900	-34%	-$4.52M	0.02%	504
2018 Q2	$14.2M	Buy	174,900 +700	+0.4%	+$49.4K	0.03%	362
2018 Q1	$13.1M	Buy	174,200 +21,100	+14%	+$1.68M	0.03%	337
2017 Q4	$11M	Buy	+153,100	New	+$11.6M	0.03%	318

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Toronto Dominion Bank's GILD Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Gilead Sciences (GILD) stake by 39% in Q1 2026, selling an estimated $38.4M and leaving 433,696 shares worth $60.4M. The position accounts for 0.09% of the portfolio, ranked #201.

Toronto Dominion Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $123M in Q1 2023. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Toronto Dominion Bank held 433,696 shares of Gilead Sciences worth $60.4M as of Q1 2026.
Toronto Dominion Bank sold 274,186 Gilead Sciences shares in Q1 2026, an estimated $38.4M.
Gilead Sciences made up 0.09% of Toronto Dominion Bank's portfolio in Q1 2026, its #201 holding.
Toronto Dominion Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's Gilead Sciences position peaked at $123M in Q1 2023.
2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.